Literature DB >> 18376337

The clinical dilemma--prescribing in pregnancy.

Roshelle Ramkisson1, Margaret Campbell, Mark Agius.   

Abstract

Antipsychotic prescription in pregnancy is a complex topic and raises a great deal of anxiety in professionals. There is limited data about atypical antipsychotic prescription in pregnancy and its possible teratogenicity. There are no randomised controlled studies of atypical antipsychotic use in pregnancy due to obvious reasons of ethical issues. We present two cases where a choice had to be made as to whether to prescribe Olanzapine during pregnancy, with different results.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18376337

Source DB:  PubMed          Journal:  Psychiatr Danub        ISSN: 0353-5053            Impact factor:   1.063


  5 in total

Review 1.  Pharmacologic interventions for pregnant women enrolled in alcohol treatment.

Authors:  Erica J Smith; Steve Lui; Mishka Terplan
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

Review 2.  Olanzapine in pregnancy and breastfeeding: a review of data from global safety surveillance.

Authors:  Elizabeth Brunner; Deborah M Falk; Meghan Jones; Debashish K Dey; Chetan Chinmaya Shatapathy
Journal:  BMC Pharmacol Toxicol       Date:  2013-08-01       Impact factor: 2.483

Review 3.  Effect of atypical antipsychotics on fetal growth: is the placenta involved?

Authors:  Sandeep Raha; Valerie H Taylor; Alison C Holloway
Journal:  J Pregnancy       Date:  2012-07-11

4.  Teratogenicity with olanzapine.

Authors:  Sathya Prakash; Rakesh Kumar Chadda
Journal:  Indian J Psychol Med       Date:  2014-01

Review 5.  Dilemma of treating schizophrenia during pregnancy: a Case series and a review of literature.

Authors:  Andreea Teodorescu; Petru Ifteni; Marius Alexandru Moga; Victoria Burtea; Nicusor Bigiu
Journal:  BMC Psychiatry       Date:  2017-08-29       Impact factor: 3.630

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.